Literature DB >> 29465401

Adherence to Anaphylaxis Guidelines: Real-World Data From the Emergency Department of a Tertiary Hospital.

L V Ponce Guevara1,2, E Laffond Yges1,2,3, M T Gracia Bara1,2, E Moreno Rodilla1,2,3, F J Muñoz Bellido1,2,3, M Lázaro Sastre1,2, E M Macías Iglesias1,2, S de Arriba Méndez1,2, M V Campanón Toro1,2, I Dávila Gónzalez1,2,3.   

Abstract

BACKGROUND AND
OBJECTIVE: Few studies have evaluated adherence to anaphylaxis guidelines in emergency departments (EDs). Objective: The objective of this study was to evaluate adherence to anaphylaxis guidelines in the ED of a tertiary hospital.
METHODS: Medical records of patients attended in the ED of University Hospital of Salamanca, Spain were reviewed. Those patients fulfilling the anaphylaxis criteria proposed by the NIAID/FAAN were selected.
RESULTS: During a 1-year period, we identified 89 patients (74 adults and 15 children). The anaphylactic reaction was moderate in 65% of adults, severe in 34%, and very severe in 1%. In children, all reactions were moderate. Fewer than half of the patients (42%) received adrenaline in the ED; this was administered intramuscularly in only 19% of cases. As for the severity of the reaction, 65% of patients with moderate reactions and 42% with severe reactions were not treated with adrenaline. At discharge from the ED, an adrenaline auto-injector was recommended to only 5.6% of patients. Fifty-two percent of patients received a documented allergy referral (57% adults vs 27% children, P=.047), 29% instructions about avoidance of triggers (31% adults vs 20% children, NS), and 51% written instructions for recognition of anaphylaxis warning signs (41% adults vs 100% children, P<.001).
CONCLUSIONS: The results of the study show a large discrepancy between recommendations in guidelines and management of anaphylaxis in the ED. Additional training efforts are needed to improve the treatment of patients with anaphylactic reactions.

Entities:  

Keywords:  Adrenaline; Anaphylaxis; Guidelines

Mesh:

Substances:

Year:  2018        PMID: 29465401     DOI: 10.18176/jiaci.0243

Source DB:  PubMed          Journal:  J Investig Allergol Clin Immunol        ISSN: 1018-9068            Impact factor:   4.333


  2 in total

1.  Is the clinical manifestation of anaphylaxis in children influenced by the trigger of reaction?

Authors:  Izabela Tarczoñ; Urszula Jedynak-Wąsowicz; Grzegorz Lis; Tomasz Tomasik; Piotr Brzyski; Ewa Cichocka-Jarosz
Journal:  Postepy Dermatol Alergol       Date:  2020-06-26       Impact factor: 1.837

2.  Use of multiple epinephrine doses in anaphylaxis: A systematic review and meta-analysis.

Authors:  Nandinee Patel; Kok Wee Chong; Alexander Y G Yip; Despo Ierodiakonou; Joan Bartra; Robert J Boyle; Paul J Turner
Journal:  J Allergy Clin Immunol       Date:  2021-04-20       Impact factor: 10.793

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.